DEVICE CATEGORY · NBW
System, Test, Blood Glucose, Over The Counter
FDA classification: Clinical Chemistry. Device class 2.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Changsha Sinocare, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| EPS Bio Technology Corp. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Vivachek Biotech (Hangzhou) Co., Ltd. | 510(k) clearance | Oct 9, 2026 | FDA | |
| I-Sens, Inc. | 510(k) clearance | Oct 2, 2026 | FDA | |
| Ascensia Diabetes Care | 510(k) clearance | Aug 27, 2026 | FDA | |
| Trividia Health, Inc. | 510(k) clearance | Jul 23, 2026 | FDA |
Source information
Follow the FDA links to view the original records.




